NCT06070935

Brief Summary

Pediatric uveitis accounts for 5-10% of uveitis cases. it may be infectious or noninfectious in etiology. The etiology of noninfectious uveitis may be autoimmune. The most common causes of pediatric uveitis are idiopathic and juvenile idiopathic arthritis-associated uveitis. Uveitis morbidities in pediatric patients include cataract, glaucoma, and amblyopia. Pediatric uveitis may be accopanied by involvement of the ocular vasculature, such as retinal vasculitis. We hypothesize that there are differences in systemic microcirculation between pediatric uveitis patients and healthy pediatric controls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
46

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Jan 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 1, 2023

Completed
5 days until next milestone

First Posted

Study publicly available on registry

October 6, 2023

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2024

Completed
Last Updated

August 15, 2024

Status Verified

August 1, 2024

Enrollment Period

5 months

First QC Date

October 1, 2023

Last Update Submit

August 14, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • capillary density by nailfold capillaroscopy

    (number of capillaries per mm)

    6 months

  • detection of number of dilated capillaries by nailfold capillaroscopy

    number of dilated capillaries (apex of \>20µm)

    6 months

  • detection of other abnormalities as avascular areas, microhemorrhages, and abnormal capillary morphology

    detection of multiple crossings, tortuous, bushy, ramified, non-convex, or bizarre capillaries

    6 months

Secondary Outcomes (1)

  • correlation of nailfold findings with uveitis activity

    6 months

Study Arms (2)

pediatric uveitis

pediatric uveitis patients \< 18 years old

healthy subjects

healthy subjects\< 18 years old

Eligibility Criteria

AgeUp to 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodProbability Sample
Study Population

pediatric uveitis patients and healthy pediatric control

You may qualify if:

  • patients with uveitis \< 18 years old

You may not qualify if:

  • infectious uveitis
  • age \> 18 years old

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maha Abdelrahman

Asyut, 71515, Egypt

Location

MeSH Terms

Conditions

Uveitis

Condition Hierarchy (Ancestors)

Uveal DiseasesEye Diseases

Study Officials

  • Maha Abdelrahman, MD, PHD

    Assiut University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal invesigator

Study Record Dates

First Submitted

October 1, 2023

First Posted

October 6, 2023

Study Start

January 1, 2024

Primary Completion

May 30, 2024

Study Completion

June 30, 2024

Last Updated

August 15, 2024

Record last verified: 2024-08

Locations